![Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome]()
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's SyndromeFleseriu, Maria; Biller, Beverly M. K.; Findling, James W.; Molitch, Mark E.; Schteingart, David E.; Gross, Coleman; Auchus, Richard; Bailey, Timothy; Biller, Beverly M. K.; Carroll, Ty; Colleran, Kathleen; Fein, Henry; Findling, James W.; Fleseriu, Maria; Hamrahian, Amir; Katznelson, Laurence; Kerr, Janice; Kipnes, Mark; Kirschner, Lawrence; Koch, Christian; Lerman, Sam; Lyons, Timothy; McPhaul, Michael; Molitch, Mark E.; Schteingart, David E.; Vaughan, T. Brooks; Weiss, Roy · The Journal of Clinical Endocrinology & Metabolism · 2012